Catalyst

Slingshot members are tracking this event:

Regeneron (REGN) and Sanofi (SNY) rheumatoid arthritis drug Kevzara (sarilumab) granted FDA approval

Source Link:
https://seekingalpha.com/news/3269168-regeneron-sanofi-rheumatoid-arthritis-drug-wins-fda-approval

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
REGN Community voting in process
SNY Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
May 22, 2017
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Kevzara (sarilumab), Rheumatoid Arthritis, Fda Approval
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.